The Max Foundation shared on LinkedIn:
“In 2001, we partnered with Novartis to develop an international treatment access program for people living with chronic myeloid leukemia (CML). Since then, together we’ve helped thousavvnds of patients in low- and middle-income countries access:
- Life-extending diagnostics
- Medication
- Support services
You can learn more about our collaboration over the past 25 years here ”